None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Men or women aged between 20 and under 80 2) Patients suspected of having active Helicobacter pylori infection on endoscopy 3) Patients who can fully understand the requirements of the clinical trial 4) Patients who agree to participate in this test and voluntarily sign a written consent form
Exclusion criteria
Exclusion criteria: 1) Patients receiving PPI or antibiotics within 2 weeks 2) Pregnant women and nursing mothers 3) Uncontrolled diabetics / Uncontrolled hypertension / Uncontrolled liver failure 4) Alcoholics 5) Patients with a history of gastrointestinal malignancy within 5 years (excluding endoscopic resection of gastric adenoma or early gastric cancer) 6) Patients who have undergone esophageal or gastrectomy 7) Patients who performed H. pylori eradication therapy before participating in the study 8) Patients who participated in other clinical trials within 30 days prior to the clinical trial 9) Other patients deemed unfit by researchers to participate in clinical trials
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Antibiotic resistance of Helicobacter pylori in Daegu and Kyungbuk, and compared with the current status of other regions. | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of Helicobacter treatment rates according to antibiotic resistance | — |
Countries
Korea, Republic of
Contacts
Kyungpook National University Medical Center